Page last updated: 2024-08-24

irinotecan and Mixed Tumor, Mesodermal

irinotecan has been researched along with Mixed Tumor, Mesodermal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azevedo, P; Deavers, MT; Freedman, RS; Kavanagh, JJ; Kudelka, AP; Lu, K; Verschraegen, CF1

Other Studies

1 other study(ies) available for irinotecan and Mixed Tumor, Mesodermal

ArticleYear
Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.
    European journal of gynaecological oncology, 2001, Volume: 22, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Enzyme Inhibitors; Female; Humans; Irinotecan; Middle Aged; Mixed Tumor, Mesodermal; Ovarian Neoplasms; Remission Induction; Topoisomerase I Inhibitors

2001